Genetics and blood testing for inherited bleeding disorders
Part of Blood & lymphatic, Genetic & congenital, Heart & circulation clinical trials.
This study looks at genes and blood function in people with inherited (passed-down) problems with platelets, white blood cells, or blood clotting. It may help improve understanding of the cause of these conditions and how they work in the body.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You must be an adult (18+) if you are enrolling as a healthy volunteer
- You may qualify if you or a relative has an inherited platelet disorder, inherited white blood cell disorder, or inherited blood clotting disorder (including von Willebrand disease)
- Tell the team if you have taken aspirin or similar anti-platelet medicine in the past week (it may affect results)
- If you have donated blood recently, you may need to meet limits on how much blood you can donate in the last 8 weeks
- If you’re a patient, your allowed blood draw depends on your recent hematocrit value (a measure in a blood test) or whether it is unknown
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study looks at people with Glanzmann thrombasthenia, a rare bleeding disorder. It aims to gather information about the condition and how it affects people, which may help improve care and treatment in the future.
This study uses special video imaging to try to predict when bleeding may happen in certain inherited bleeding disorders. It may help doctors better anticipate bleeding and guide safer care.
This trial is testing a medication called eptacog beta (a clotting factor) to see if it helps control or prevent severe bleeding episodes in people with Glanzmann's thrombasthenia, a rare inherited bleeding disorder.
This study looks at the symptoms, severity, and outcomes of bleeding in children with Glanzmann thrombasthenia who are admitted to the hospital for active bleeding. It aims to understand the clinical pattern to improve care and treatment.
This trial uses early genetic testing to find the cause of unexplained bleeding in people who may have an inherited bleeding disorder. The goal is to see if genetic testing can help diagnose these conditions sooner.
This Swiss study looks at people with unexplained bleeding by using a standardized bleeding score and taking a blood sample. It may help researchers better understand possible bleeding causes even when the reason isn’t clear yet.
Hear when a new Glanzmann Thrombasthenia trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.